The latest closing stock price for Fulcrum Therapeutics as of September 19, 2024 is 3.45.
An investor who bought $1,000 worth of Fulcrum Therapeutics stock at the IPO in 2019 would have $-744 today, roughly -1 times their original investment - a -23.88% compound annual growth rate over 5 years.
The all-time high Fulcrum Therapeutics stock closing price was 30.97 on September 20, 2021.
The Fulcrum Therapeutics 52-week high stock price is 13.70, which is 297.1% above the current share price.
The Fulcrum Therapeutics 52-week low stock price is 2.87, which is 16.8% below the current share price.
The average Fulcrum Therapeutics stock price for the last 52 weeks is 7.12.
An investor who bought $1,000 worth of Fulcrum Therapeutics stock at the IPO in 2019 would have $-744 today, roughly -1 times their original investment - a -23.88% compound annual growth rate over 5 years.
The all-time high Fulcrum Therapeutics stock closing price was 30.97 on September 20, 2021.
The Fulcrum Therapeutics 52-week high stock price is 13.70, which is 297.1% above the current share price.
The Fulcrum Therapeutics 52-week low stock price is 2.87, which is 16.8% below the current share price.
The average Fulcrum Therapeutics stock price for the last 52 weeks is 7.12.